Pexiganan vs Ponericin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Pexiganan (MSI-78) is a synthetic analog of magainin-2, optimized for enhanced broad-spectrum antimicrobial activity and reduced hemolytic toxicity. It was developed by Magainin Pharmaceuticals (later Genaera) as a topical treatment for mildly infected diabetic foot ulcers....
Calculate Pexiganan dose →Ponericins are a family of antimicrobial peptides isolated from the venom of the ant Pachycondyla goeldii. They adopt alpha-helical conformations in membrane environments and display broad-spectrum antibacterial and insecticidal activity....
Calculate Ponericin dose →| Parameter | Pexiganan | Ponericin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Phase 3 (Failed 1999) | Preclinical |
| Half-Life | Hours (topical) | Short |
| Typical Dose | 0.8% cream topically | N/A (research only) |
| Frequency | Twice daily | N/A |
| Route | Topical cream | Topical / Systemic (research) |
| FDA Status | Not approved (failed Phase 3) | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.